← All investors
CARB-X
31 portfolio companies · 4 on the map · $471M raised · 4 cities
Portfolio map
4 CARB-X portfolio companies on the map.
Portfolio companies
Vedanta Biosciences
Cambridge
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
Biotechnology Research$437M
LimmaTech Biologics
Zurich
Better technology for better health
Biotech$34MEst. 2018
Melinta Therapeutics
Parsippany
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
Biotechnology ResearchPublicHiring fast
Melio
New York
Melio is a fintech company that delivers a digital accounts payable and receivable platform tailored for small and medium-sized businesses.
Financial ServicesSeries EEst. 2018
More portfolio companies
27 more CARB-X investments we track beyond the map.
Debiopharm GroupLausanne · Grant
BioVersysBasel · Grant
Locus BiosciencesMorrisville · Grant
ShionogiOsaka-shi · Grant
Cellics TherapeuticsSan Diego · Grant
Day Zero DiagnosticsBoston · Grant
University of EdinburghEdinburgh · Grant
Macro BiologicsCarlsbad · Grant
AffinivaxCambridge · Grant
Eligo BioscienceParis · Grant
Centauri TherapeuticsAlderley Park · Grant
BaebiesDurham · Grant
IdorsiaAllschwil · Grant
Venatorx PharmaceuticalsMalvern · Grant
Iterum TherapeuticsDublin · Grant
Spero TherapeuticsCambridge · Grant
GlaxoSmithKlineLondon · Grant
Oxford Drug DesignOxford · Grant
Basilea PharmaceuticaBasel · Grant
GenomeKeyBristol · Grant
Helmholtz Centre for Infection ResearchBraunschweig · Grant
Accelerate DiagnosticsTucson · Grant
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)Saarbrücken · Grant
ContraFectYonkers · Grant
Entasis TherapeuticsWaltham · Grant
Tetraphase PharmaceuticalsWatertown · Grant
University of QueenslandSaint Lucia · Grant
Portfolio map
4 CARB-X portfolio companies on the map.